newsfilter
← Latest News
Business Wire·

Axonics to Report Fourth Quarter 2022 Financial Results on March 1

Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, will report fourth quarter 2022 financial